FCGR3A and thymoma: The results are presented in Figures 3A–C, in terms of overall survival (OS), FCGR3A was an independent risk prognostic factor in KIRC (p = 0.026, HR = 1.163), LGG (p < 0.001, HR = 1.317), thymoma (THYM) (p = 0.026, HR = 1.649) and uveal melanoma (UVM) (p = 0.011, HR = 1.326), but was a protective prognostic factor in SKCM (p < 0.001, HR = 0.814).